Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis
Molecular Pharmaceutics · 01.06.2026 · 23 (6) · 3265-3275
DOI: 10.1021/acs.molpharmaceut.5c01766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 19.05.2026. Verfasst von Darren R Veach und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Heterocyclic Compounds, 1-Ring, Radioimmunotherapy, Radiopharmaceuticals. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
- Department of Radiology, Weill Cornell Medicine, New York, New York 10021, United States.
- Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
- Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York 10021, United States.
- Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
- Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
ORCID-Profile: Naga Vara Kishore Pillarsetty, Nai-Kong V Cheung, Steven M Larson
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Veach, D. R., Burnes Vargas, D., Islam, B., Lee, S. G., Gajecki, L., Vaughn, B. A., Yang, G., Kalidindi, T. M., Pillarsetty, N. V. K., Salehi, N., Jaswal, A. P., Saha, S., Le Roux, A. B., Xu, H., Guo, H. F., Ouerfelli, O., Cheung, N. V., Krebs, S., Larson, S. M., & Cheal, S. M. (2026). Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis. Molecular Pharmaceutics, 23(6), 3265-3275. https://doi.org/10.1021/acs.molpharmaceut.5c01766
Vancouver
Veach DR, Burnes Vargas D, Islam B, Lee SG, Gajecki L, Vaughn BA, et al. Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis. Molecular Pharmaceutics. 2026;23(6):3265-3275. doi:10.1021/acs.molpharmaceut.5c01766
BibTeX
@article{Veach2026,
author = {Veach, Darren R and Burnes Vargas, Daniela and Islam, Baharul and Lee, Sang Gyu and Gajecki, Leah and Vaughn, Brett A and Yang, Guangbin and Kalidindi, Teja Muralidhar and Pillarsetty, Naga Vara Kishore and Salehi, Niloufar and Jaswal, Ambika P and Saha, Sayani and Le Roux, Alexandre B and Xu, Hong and Guo, Hong-Fen and Ouerfelli, Ouathek and Cheung, Nai-Kong V and Krebs, Simone and Larson, Steven M and Cheal, Sarah M},
title = {Establishment of 68 Ga-DOTA-Based Pretargeted Radioimmunodiagnosis},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {6},
pages = {3265--3275},
doi = {10.1021/acs.molpharmaceut.5c01766}
}
EUVIMED